Rinske Boersma

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Michèle Cavo, Francesca Gay, Meral Beksaç et al. · The Lancet Haematology · 2020 · 384 citations · Full text

Medicine, Hematology, Oncology +17

Hydrophilic surface coatings with embedded biocidal silver nanoparticles and sodium heparin for central venous catheters

Kris Stevens, Sander Croes, Rinske Boersma et al. · Biomaterials · 2010 · 105 citations

Natural Sciences, Biomedical Engineering, Materials Science +17

Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial

Martine E.D. Chamuleau, Coreline N. Burggraaff, Marcel Nijland et al. · Haematologica · 2019 · 53 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Ibrutinib added to 10-day decitabine for older patients with AML and higher risk MDS

Gerwin Huls, Dana Chiţu, Thomas Pabst et al. · Blood Advances · 2020 · 32 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Clinical practices concerning central venous catheters in haematological patients

Rinske Boersma, Harry C. Schouten · European Journal of Oncology Nursing · 2010 · 23 citations

Nursing, Hematology, Hematology Nursing +12